Product Name | MF | CAS | Details |
---|
2-Pyridinamine, 3-[(1R)-1-(2-chloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- | C21H23ClFN5O | 1801651-84-2 | Details |
Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate | C25H21FIN3O6S | 871700-32-2 | Details |
Dasatinib Impurity 1 | Details |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one | C25H26N6O2 | 1839099-22-7 | Details |
Palbociclib-025 | C25H29N7O3 | 2174002-16-3 | Details |
2-(Cyclohept-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H23BO2 | 287944-13-2 | Details |
Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide | C26H23FIN5O4 | 871700-25-3 | Details |
6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one | C15H18N4O2 | 571189-64-5 | Details |
Bis[2-(diphenylphosphino)phenyl] ether oxide | C36H28O3P2 | 808142-23-6 | Details |
(S)-Crizotinib | C21H22Cl2FN5O | 1374356-45-2 | Details |
Ibrutinib Dimer Impurity | C50H48N12O4 | 2031255-23-7 | Details |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- | C16H18N6O | 2606144-45-8 | Details |
Crizotinib Impurity 39 | C23H26Cl2FN5O | 1428476-77-0 | Details |
4,6-Dichloro-2-methylpyrimidine | C5H4Cl2N2 | 1780-26-3 | Details |
Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
1-methyl-1H-imidazole-5-boronic acid pinacol este | C10H17BN2O2 | 942070-72-6 | Details |
2-Amino-1-morpholinoethanone | C6H12N2O2 | 56414-96-1 | Details |
2,6-Dibromo-8-Cyclopentyl-5-Methylpyrido[2,3-D]Pyrimidin-7(8H)-One | C13H13Br2N3O | 1415560-29-0 | Details |
Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone | C24H24N6O2 | 1288338-95-3 | Details |
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, anhydride with 2-methylpropyl hydrogen carbonate | C12H21NO6 | 66866-43-1 | Details |
Pomalidomide | C13H11N3O4 | 19171-19-8 | Details |
Dasatinib DiMeric IMpurity | C36H34Cl2N12O2S2 | 910297-61-9 | Details |
Palbociclib Impurity | C22H28ClN7O | Details |
6-bromo-8-cyclopentyl-5-methyl-Pyrido[2,3-d]pyrimidine-2,7(1H,8H)-dione | C13H14BrN3O2 | 1922954-32-2 | Details |
LenalidoMide | C13H13N3O3 | 191732-72-6 | Details |
6-aMino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyriMidine-2,4(1H,3H)-dione | C13H11FIN3O2 | 871700-28-6 | Details |
lenvatinib Mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
1-Piperazinecarboxylic acid, 4-(2-aMino-3-pyridinyl)-, 1,1-diMethylethyl ester | C14H22N4O2 | 1023594-49-1 | Details |
Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | C16H13Cl2N5OS | 302964-08-5 | Details |
Clozolidine dechlorination impurity | C16H13Cl2FN4O | 3026867-46-6 | Details |
N'-[1-Cyclopropyl-3-(2-fluoro-4-iodophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]-N,N-dimethylformamidine | C16H16FIN4O2 | 871700-30-0 | Details |
8-Cyclopentyl-5-methyl-2-[[(5-piperazin-1-ylpyridin-2-yl)]amino]-8H-pyrido[2,3-d]pyrimidin-7-one | C22H27N7O | 571190-22-2 | Details |
Ibrutinib Impurity | C50H48N12O4 | 2417548-76-4 | Details |
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | C11H10ClN3OS | 302964-24-5 | Details |
N-Nitroso tadalafil | Details |
Dasatinib N-Oxide | C22H26ClN7O3S | 910297-52-8 | Details |
1,3-bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one | C47H46N12O3 | 1987905-93-0 | Details |
Ruxolitinib Impurity2 | Details |
N-Nitroso Anabasine | C10H13N3O | 37620-20-5 | Details |
Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | C9H12N2O3 | 518990-21-1 | Details |
1-(4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one | C25H24N6O2 | 936563-92-7 | Details |
2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | C12H16BF2NO2 | 939968-08-8 | Details |
N-Nitroso Avanafil | Details |
N-Nitroso Argatroban | Details |
2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide (Dasatinib Impurity) | C22H27N7O2S | 1184919-23-0 | Details |
1-(2-Hydroxyethyl)piperazine | C6H14N2O | 103-76-4 | Details |
5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]- | C16H18N6O2 | 2606144-44-7 | Details |
(E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide | C12H14ClNO2 | 863127-76-8 | Details |
Sorafenib tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
GSK1120212 (DMSO solvate) | C28H29FIN5O5S | 1187431-43-1 | Details |
Nilotinib Hydrochloride | C28H23ClF3N7O | 923288-95-3 | Details |
4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester | C27H35N7O3 | 571189-65-6 | Details |
4-Chloro-7-trityl-7h-pyrrolo[2,3-d]pyrimidine | C25H18ClN3 | 1792190-52-3 | Details |
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-methoxy-1-propanone | C26H28N6O3 | 2031255-26-0 | Details |
Palbociclib Impurity | C24H29N7O2 | 2204368-66-9 | Details |
Ruxolitinib Impurity5 | 2231734-31-7 | Details |
Ruxolitinib Impurity3 | C17H21N6O4P | 2703484-89-1 | Details |
tert-Butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate | C9H15F3N2O3 | 1231755-15-9 | Details |
N-Deshydroxyethyl Dasatinib | C20H22ClN7OS | 910297-51-7 | Details |
6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one | C22H26BrN7O | 851067-56-6 | Details |
N-Nitroso Belumosudil | Details |
Ruxolitinib Impurity1 | C25H29N7 | 3027185-21-0 | Details |
N-Nitroso Amoxapine | Details |
Palbociclib-007 | C14H18N6 | 2144748-14-9 | Details |
N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide | C15H16N2O3S | 329941-39-1 | Details |
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | C9H7N5 | 952518-97-7 | Details |
Ethanone, 1-[4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-pyridinyl]-1H-pyrazol-1-yl]-1-piperidinyl]- | C23H24Cl2FN5O2 | 2925080-43-7 | Details |
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- | C17H20N6O | 1911644-32-0 | Details |
N-Nitroso Bendroflumethiazide | Details |
N-Nitroso desmethyl Amitriptyline | C19H20N2O | 55855-42-0 | Details |
N-Nitroso Acebutolol | Details |
N-Nitroso desmethyl Bedaquiline | Details |
Pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione, 1-(3-aminophenyl)-3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl- | C24H21FIN5O3 | 871701-87-0 | Details |
Ruxolitinib Impurity4 | C18H20N6O | 41685-37-6 | Details |
Ruxolitinib Impurity6 | 3016399-18-8 | Details |
Dasatinib Impurity 44 | C18H24ClN5O | 2099694-53-6 | Details |
2-[[6-[4-(2-Hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxylic acid | C15H20N6O3S | 1245157-42-9 | Details |
1-Piperazinecarboxylic acid, 4-[6-(acetylamino)-3-pyridinyl]-, 1,1-dimethylethyl ester | C16H24N4O3 | 1311611-88-7 | Details |
2-bromo-3-methylpropiophenone | C10H11BrO | 1451-83-8 | Details |
Acetamide, N-[4-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- | C26H23FIN5O4 | 871701-23-4 | Details |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester | C29H37N7O3 | 1941177-45-2 | Details |
N-Nitroso desmethyl Almotriptan | Details |
Deiodo Trametinib | C26H24FN5O4 | 871700-65-1 | Details |
N-Nitroso Albuterol | C13H20N2O4 | 2919946-71-5 | Details |
N-Nitroso Avacopan | Details |
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- | C17H19N5O2 | 2102675-40-9 | Details |
N-Nitroso Benzonatate | Details |
Benzenebutanoic acid, γ-cyano-3,4-dimethoxy-γ-(1-methylethyl)-, (γS)-, compd. with (αR)-α-methylbenzenemethanamine (1:1) | C16H21NO4.C8H11N | 194854-18-7 | Details |
C17H17FIN3O3 | 3018911-27-5 | Details |
Product Total: Product Page: | ||||
1 2 |